Everything about lung cancer is here.
The National Institute of Health and Care Excellence (NICE) has announced the recommendation of Tagrisso (osimertinib) for routine use in
The Food and Drug Administration (FDA) has approved Gavreto (pralsetinib) for treatment of patients with metastatic non-small cell lung cancer
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in